По вашему запросу найдено документов: 273

Страница 1 из 28

SAFETY AND TOLERABILITY OF ONCE-WEEKLY ADMINISTRATION OF CTP-MODIFIED HUMAN GROWTH HORMONE (MOD-4023): 24-MONTH COMPLETE DATASET RESULTS OF A PHASE 2 STUDY IN CHILDREN WITH GROWTH HORMONE DEFICIENCY
Zelinska, N., Skorodokb, J., Malievsky, O., Rosenfeldd, Ron G., Zadike, Zvi, Korenf, R., Vanderf, Sh., Hartf, G., Radziukg, K. (2016)
and children. Objective and hypotheses: In the present Phase 2 study, the safety and tolerability of once
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
Maniatis, AK;, Casella, SJ;, Nadgir, UM;, Hofman, PL;, Saenger, P;, Chertock, ED;, Aghajanova, EM;, Korpal-Szczyrska, M;, Vlachopapadopoulou, E;, Malievskiy, O;, Chaychenko, T;, Cappa, M;, Song, WJ;, Mao, M;, Mygind, PH;, Smith, AR;, Chessler, S;, Komirenko, AS;, Beckert, M;, Aimee, D Shu, Paul, S Thornton (2022)
the long-term safety and efficacy of weekly administered long-acting growth hormone lonapegsomatropin
LONG-ACTING C-TERMINAL PEPTIDE-MODIFIED HGH (MOD-4023): RESULTS OF A SAFETY AND DOSE-FINDING STUDY IN GHD CHILDREN
Zelinska, N., Iotova, V., Skorodok, J., Malievsky, O., Peterkova, V., Samsonova, L., Rosenfeld, Ron G., Zadik, Zvi, Jaron-Mendelson, Michal, Koren, Ronit, Amitzi, Leanne, Raduk, Dmitri, Hershkovitz, Oren, Hart, Gili (2017)
the safety, tolerability, pharmacokinetics/pharmacodynamics, and efficacy of three different weekly MOD-4023
Phase I/II trial of local interstitial chemotherapy with arsenic trioxide in patients with newly diagnosed glioma
Han, Dayong, Teng, Lei, Wang, Xiaoxiong, Zhen, Yunbo, Chen, Xiaofeng, Yang, Mingchun, Gao, Ming, Yang, Guang, Han, Mingyang, Wang, Ligang, Xu, Jiajun, Li, Yue, Shumadalova, Alina, Zhao, Shiguang (2022)
the efficiency and safety of srsenic trioxide in glioma patients. Objective: The arsenic trioxide has the potent
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
Deal, C, Steelman, J, Vlachopapadopoulou, E, Stawerska, R, Silverman, LA;, Phillip, M, Kim, HS, Ko, CW, Malievskiy, O, Cara, JF, Roland, CL, Taylor, CT, Valluri, SR, Wajnrajch, MP, Pastrak, A, Miller, BS (2022)
the efficacy and safety of once-weekly somatrogon with once-daily somatropin in prepubertal children with GHD
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
Maniatis, Aristides K., Thornton, Paul S., Nadgir, Ulhas M., Vlachopapadopoulou, Elpis, Malievskiy, Oleg, Aghajanova, Elena M., Korpal-Szczyrska, Maria, Woods, Katie A., Mao, Meng, Zhao, Carol, Abdelrahman, Sohair G., Huang, Eric A., Komirenko, Allison S., Shu, Aimee D., Shu, A.D., Hofman, Paul (2025)
-term safety and efficacy of once-weekly lonapegsomatropin in children with growth hormone deficiency (GHD
Первый объединенный российский опыт применения перампанела у детей и подростков с эпилепсией в повседневной клинической практике
The first combined russian experience of using perampanel in children and adolescents with epilepsy in everyday clinical practice
Rakhmanina, O.A., Volkov, I.V., Volkova, O.K., Aleksandrov, Y.A., Barkhatov, M.V., Bakhtin, I.S., Berezhnaya, G.M., Boldyreva, S.R., Bochkova, , E.N., Gorbunova, E.K., Karas, A. Yu., Morozov, D. V., Nurmukhametova, S. R., Perunova, N. Yu., Sivkova, S. N., Telegina, E. V., Tomenko, T. R., Tsotsonava, Zh. M., Рахманина, О.А., Волков, И.В., Волкова, О.К., Александров, Ю.А., Бархатов, М.В., Бахтин, И.С., Бережная, Г.М., Болдырева, С.Р., Бочкова, Е.Н., Горбунова, Е.К., Карась, А.Ю., Морозов, Д.В., Нурмухаметова, С.Р., Перунова, Н.Ю., Сивкова, С.Н., Телегина, Е.В., Томенко, Т.Р., Цоцонава, Ж.М. (2022)
efficacy and tolerability
Новая наномицеллярная форма латанопроста 0,005 % в терапии первичной открытоугольной глаукомы
New Nanomicellar Form of Latanoprost 0,005 % in Treatment Open Angle Glaucoma
Dukhanin, A.S., Zagidullina, A.Sh., Azamatova, G.A., Духанин, А. С., Загидуллина, А. Ш., Азаматова, Г. А. (2024)
СЛУЧАЙ ЯТРОГЕННОГО БОТУЛИЗМА ПРИ БОТУЛИНОТЕРАПИИ В КЛИНИЧЕСКОЙ ПРАКТИКЕ
Case of iatrogenic botulism after botulinotherapy in clinical practice
ИБАТУЛЛИН, РОБЕРТ АЛЬБЕРОВИЧ, МАГЖАНОВ, РИМ ВАЛЕЕВИЧ, Ibatullin, R.A., Magjanov, R.V. (2018)
relaxation. It has been acknowledged that treatment with BTA has very good safety profile and tolerability
Effects of Pseudomonas sp. OBA 2.4.1 on Growth and Tolerance to Cadmium Stress in Pisum sativum L.
Khakimova, Liliya, Chubukova, Olga, Vershinina, Zilya, Maslennikova, Dilara (2023)
. It was revealed that strain OBA 2.4.1 is tolerant of up to 2 mM CdCl2, and seed treatment with the bacterium

Страница 1 из 28

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год